Conference Coverage

Survey Spotlights Identification of Dermatologic Adverse Events From Cancer Therapies

Publish date: May 13, 2024

 

FROM AAD 2024

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

PCOS: Laser, Light Therapy Helpful for Hirsutism
MDedge Family Medicine
Keratoacanthoma, SCC Relatively Rare With PD-1/PD-L1 Inhibitors, Study Suggests
MDedge Family Medicine
Time to Lung Disease in Patients With Dermatomyositis Subtype Estimated
MDedge Family Medicine
Are Direct-to-Consumer Microbiome Tests Clinically Useful?
MDedge Family Medicine
The Long, Controversial Search for a ‘Cancer Microbiome’
MDedge Family Medicine
Do Health-Related Social Needs Raise Mortality Risk in Cancer Survivors?
MDedge Family Medicine
Do Patients Benefit from Cancer Trial Participation?
MDedge Family Medicine
Study Evaluates CVD, Mortality Risks In Patients With Prurigo Nodularis
MDedge Family Medicine
Can a Risk Score Predict Kidney Injury After Cisplatin?
MDedge Family Medicine
New mRNA Vaccines in Development for Cancer and Infections
MDedge Family Medicine